Company / Profit Margin
Sarepta Therapeutics Profit Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-32.5%
FY2025
5-year range
-102.6% / 12.4%
FY2021-FY2025
Trend
-362.3%
vs FY2024
Sector context
#82 of 146
Health Care
What the data says
Profit Margin changed -362% YoY in FY2025, a notable deviation from the 9-year average annual change of -62%.
Based on SEC 10-K filings.
-32.5% in FY2025 with a 5-year CAGR of +87.8%.
Improved from -43.1% to -32.5% over the past 2 years.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- +70.2pp
- 5-Year Change
- +87.8pp
- 10-Year Change
- -
Sector benchmark
#82 of 146 in Health CareTop 56% of 146This company -32.5% Sector average -796.3%
▼
+95.9% above sector average
Key checks
Key Insights
- In FY2025, profit margin decreased 362.3% year-over-year.
- Currently 763.8pp above the Health Care sector average.
- Peak profit margin was recorded in FY2024.
- Lowest profit margin in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -0.70 (distress zone, below 1.8 threshold)
- Negative profit margin: -11.3%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -32.5% | -362.3% |
| FY2024 | 12.4% | +128.7% |
| FY2023 | -43.1% | +58.0% |
| FY2022 | -102.6% | -72.0% |
| FY2021 | -59.7% | +50.4% |
| FY2020 | -120.2% | -266.6% |
| FY2019 | -32.8% | +72.7% |
| FY2018 | -120.2% | -266.6% |
| FY2017 | -32.8% | +99.3% |
| FY2016 | -4930.2% | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026